This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A.
Learning Objectives:
Describe the burden, unmet needs, and management challenges associated with fistulizing CD
Evaluate the most recent clinical data associated with newer and emerging therapies for fistulizing CD
Implement coordinated, patient-centered management strategies based on the most current evidence and consensus-based guidelines for the management of fistulizing CD
Presentations:
8:15 AM - 8:45 AM .
Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
Speaker: Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his) – Cleveland Clinic
